Zafgen Completes Phase 2 Clinical Trial Enrollment For Obesity Therapy Beloranib
News
Zafgen, a biotechnology company developing treatments for obesity and complex metabolic disorders, recently announced the completion of patient recruitment for ZAF-203, a ... Read more